Disclosures: Ana Maria Davila Morales: Nothing to Disclose, Nancy Reau: Gilead: Grant/Research Support, eiger: Grant/Research Support, abbott: Consultant, Arbutus: Consultant, Gilead: Consultant, VIR: Consultant, Salix: Consultant, Salix: Grant/Research Support, AbbVie: Grant/Research Support, Zoe Post: Nothing to Disclose, Kesany Boupapanh: Nothing to Disclose 2337 HISTOLOGICAL STAGE AS PREDICTOR OF THE COMPLICATIONS OF PRIMARY BILIARY CHOLANGITIS Tadashi Namisaki 1 Yukihisa Fujinaga 2 Shinya Sato 2 NORIHISA NISHIMURA 2 KOSUKE KAJI 2 Hitoshi Yoshiji 2 , 1 Na, 2 Nara Medical University Background: This study aimed to clarify the predictive ability of histological stage (HS) in comparison with biochemical response to ursodeoxycholic Acid (UDCA) (BR) for the development of complications in patients with primary biliary cholangitis (PBC)
Coelho LM, Rezende HC, Coelho LM, de Sousa PA, Melo DF, Coelho NM
The Anopheles gambiae glutathione transferase supergene family: annotation, phylogeny and expression profiles
Neumi Neuro Supplement is a precision-crafted formula designed to support cognitive energy, clarity, and overall wellness